Brain Insulin Resistance in Mood Disorders
Brain Insulin Resistance and Motivation in Mood Disorders
Sponsor: University Health Network, Toronto
A PHASE1/PHASE2 clinical study on Anhedonia and Bipolar Disorder, this trial is ongoing. The trial is conducted by University Health Network, Toronto and has accumulated 10 data snapshots since 2021. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.
Status Flow
Change History
10 versions recorded-
Feb 2026 — Present [monthly]
Unknown PHASE1/PHASE2
Status: Recruiting → Unknown
-
Sep 2024 — Feb 2026 [monthly]
Recruiting PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jan 2024 — Jul 2024 [monthly]
Recruiting PHASE1_PHASE2
-
Jun 2023 — Jan 2024 [monthly]
Recruiting PHASE1_PHASE2
▶ Show 5 earlier versions
-
Nov 2021 — Jun 2023 [monthly]
Recruiting PHASE1_PHASE2
Status: Not Yet Recruiting → Recruiting
-
Oct 2021 — Nov 2021 [monthly]
Not Yet Recruiting PHASE1_PHASE2
Phase: EARLY_PHASE1 → PHASE1_PHASE2
-
Jan 2021 — Oct 2021 [monthly]
Not Yet Recruiting EARLY_PHASE1
-
Jul 2019 — Jan 2021 [monthly]
Not Yet Recruiting EARLY_PHASE1
-
May 2019 — Jul 2019 [monthly]
Not Yet Recruiting EARLY_PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University Health Network, Toronto
For direct contact, visit the study record on ClinicalTrials.gov .